Complications Associated With High-dose Corticosteroid Administration in Children With Spinal Cord Injury

Jason M Cage1, Jeffrey B Knox, Robert L Wimberly

  • 1*Tripler Army Medical Center, Orthopedic Surgery Service, Honolulu, HI †Department of Orthopedics, Texas Scottish Rite Hospital for Children and Children's Medical Center, Dallas, TX ‡Center for Policy & Public Administration, Principal Outcomes Consultant, Draper, UT.

Insights

High-dose steroids for pediatric spinal cord injuries did not increase infection rates, contrary to adult data. Hyperglycemia occurred in all patients, but infections were lower in the steroid group.

Area of Science:

  • Pediatric Traumatology
  • Neurology
  • Pediatric Critical Care

Background:

  • Complications of high-dose steroid use in adult spinal cord injury (SCI) are known.
  • Limited data exists on early complications in pediatric SCI patients receiving this therapy.

Purpose of the Study:

  • To determine the incidence of early complications associated with high-dose steroid administration in pediatric SCI patients.
  • To compare complication rates between pediatric SCI patients who received high-dose steroids and those who did not.

Main Methods:

  • Retrospective review of pediatric SCI patients (2003-2011) at a level 1 trauma center.
  • Complications categorized into infectious, gastrointestinal (GI), hyperglycemia/endocrine, and wound healing.
  • Statistical comparison using Student's t test and Fischer's exact test.

Main Results:

  • Thirty-four pediatric SCI patients were analyzed; 23 received steroids, 11 did not.
  • Hyperglycemia was present in all patients, irrespective of steroid treatment.
  • The steroid group had significantly lower overall infection rates (26% vs. 64%) and respiratory tract infections (9% vs. 45%) compared to the control group.

Conclusions:

  • High-dose steroids in pediatric SCI patients were not associated with increased infection rates.
  • Hyperglycemia is a common finding in pediatric SCI, regardless of steroid use.
  • Further multicenter prospective studies are necessary to fully elucidate risks in this population.
Abstract

Related Concept Videos

Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
9
Spinal Cord Injury ll: Pathophysiology01:14

Spinal Cord Injury ll: Pathophysiology

Spinal cord injury progresses through two interconnected phases: primary injury and secondary injury.Primary InjuryPrimary injury happens at the moment of trauma and involves immediate mechanical damage to the spinal cord.Compression happens when broken vertebrae, herniated discs, or accumulating blood (such as a hematoma) press directly against the spinal cord, distorting its normal shape and function. In cases of contusion, the cord is bruised by a blunt force (like penetrating injuries or...
7
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
4.2K
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features...
1
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the...
13
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
1.1K